Invested Business? Invest in Marketing
With so much research and development taking place in the early stages of your...
read moreCombination will identify amyloid-positive subjects more efficiently and help reduce screening failure rates in clinical trials 24th July 2016, Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, has announced the launch of its SNPfitR™ software today at the Alzheimer’s Association International Conference, Toronto, Canada, for interpretive analysis…
read more
